Skip to main content
MEDP
NASDAQ Industrial Applications And Services

Medpace President Resigns; CEO August Troendle Temporarily Reassumes Role

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$420.01
Mkt Cap
$14.521B
52W Low
$250.05
52W High
$628.916
52W Position info
68% above low
Off High info
33% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MEDP sits 68% above its 52-week low of $250.05.

Summary

Medpace Holdings announced the resignation of its President, Jesse Geiger, effective May 31, 2026, with CEO August Troendle temporarily reassuming the role, alongside formalizing strong Q1 results and positive 2026 guidance.


Key Events · Executive and Board Changes · MEDP

  • President Resigns

    Jesse Geiger notified the company of his intent to resign as President and retire effective May 31, 2026. The company stated this departure is not the result of any disagreement.

  • CEO Assumes Interim Role

    Effective upon Mr. Geiger's resignation, CEO August Troendle will temporarily reassume the role of President until a successor is appointed.

  • Strong Q1 Financial Results Formalized

    The company reported Q1 2026 revenue of $706.6 million, a 26.5% increase year-over-year, and diluted GAAP EPS of $4.28. This formalizes results previously reported by news outlets on April 22, 2026.

  • Positive 2026 Guidance Formalized

    Medpace provided full-year 2026 revenue guidance of $2.755 billion to $2.855 billion and diluted GAAP EPS guidance of $16.68 to $17.50. This formalizes guidance previously reported by news outlets on April 22, 2026.


Analysis · MEDP · Industrial Applications And Services

This 8-K reports the resignation of President Jesse Geiger, effective May 31, 2026. While the company states the departure is not due to any disagreement, the resignation of a key executive is a notable event. CEO August Troendle will temporarily take on the President role, providing continuity during the transition. The filing also formalizes the company's strong first-quarter financial results and positive full-year 2026 guidance, which were previously reported by news outlets.

At the time of this filing, MEDP was trading at $420.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $14.5B. The 52-week trading range was $250.05 to $628.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEDP - Latest Insights

MEDP
Jul 23, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $602.02
Real-time Price: $608.00 info
Change: +$5.98 (+0.99%) info
Market Cap: $16.786B info
MEDP
Jul 22, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $605.00
Real-time Price: $608.00 info
Change: +$3.00 (+0.50%) info
Market Cap: $16.786B info
MEDP
Jun 16, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $461.60
Real-time Price: $608.00 info
Change: +$146.40 (+32%) info
Market Cap: $16.786B info
MEDP
Jun 04, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $458.69
Real-time Price: $608.00 info
Change: +$149.31 (+33%) info
Market Cap: $16.786B info
MEDP
May 26, 2026, 6:18 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $432.80
Real-time Price: $608.00 info
Change: +$175.20 (+40%) info
Market Cap: $16.786B info